nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—PGR—ovarian cancer	0.482	0.613	CbGaD
Desogestrel—ESR1—ovarian cancer	0.304	0.387	CbGaD
Desogestrel—PGR—corpus luteum—ovarian cancer	0.0182	0.196	CbGeAlD
Desogestrel—PGR—ovarian follicle—ovarian cancer	0.0142	0.153	CbGeAlD
Desogestrel—ESR1—ovarian follicle—ovarian cancer	0.0111	0.12	CbGeAlD
Desogestrel—PGR—oviduct—ovarian cancer	0.00626	0.0673	CbGeAlD
Desogestrel—ESR1—oviduct—ovarian cancer	0.0049	0.0526	CbGeAlD
Desogestrel—Neoplasm—Altretamine—ovarian cancer	0.00308	0.057	CcSEcCtD
Desogestrel—PGR—myometrium—ovarian cancer	0.002	0.0215	CbGeAlD
Desogestrel—PGR—epithelium—ovarian cancer	0.00157	0.0169	CbGeAlD
Desogestrel—ESR1—myometrium—ovarian cancer	0.00157	0.0168	CbGeAlD
Desogestrel—SHBG—endometrium—ovarian cancer	0.00156	0.0168	CbGeAlD
Desogestrel—PGR—uterine cervix—ovarian cancer	0.00156	0.0168	CbGeAlD
Desogestrel—ESR1—embryo—ovarian cancer	0.00151	0.0162	CbGeAlD
Desogestrel—PGR—decidua—ovarian cancer	0.00149	0.016	CbGeAlD
Desogestrel—SHBG—gonad—ovarian cancer	0.00145	0.0156	CbGeAlD
Desogestrel—Breast cancer—Docetaxel—ovarian cancer	0.00144	0.0267	CcSEcCtD
Desogestrel—SHBG—uterus—ovarian cancer	0.00144	0.0155	CbGeAlD
Desogestrel—PGR—endometrium—ovarian cancer	0.00141	0.0152	CbGeAlD
Desogestrel—PGR—uterus—ovarian cancer	0.0013	0.014	CbGeAlD
Desogestrel—SHBG—female reproductive system—ovarian cancer	0.0013	0.0139	CbGeAlD
Desogestrel—ESR1—epithelium—ovarian cancer	0.00123	0.0132	CbGeAlD
Desogestrel—SHBG—bone marrow—ovarian cancer	0.00122	0.0132	CbGeAlD
Desogestrel—ESR1—uterine cervix—ovarian cancer	0.00122	0.0131	CbGeAlD
Desogestrel—SHBG—female gonad—ovarian cancer	0.00118	0.0127	CbGeAlD
Desogestrel—SHBG—vagina—ovarian cancer	0.00117	0.0126	CbGeAlD
Desogestrel—PGR—female reproductive system—ovarian cancer	0.00117	0.0126	CbGeAlD
Desogestrel—ESR1—decidua—ovarian cancer	0.00116	0.0125	CbGeAlD
Desogestrel—ESR1—endometrium—ovarian cancer	0.0011	0.0118	CbGeAlD
Desogestrel—Neoplasm—Chlorambucil—ovarian cancer	0.0011	0.0203	CcSEcCtD
Desogestrel—PGR—female gonad—ovarian cancer	0.00106	0.0114	CbGeAlD
Desogestrel—PGR—vagina—ovarian cancer	0.00106	0.0114	CbGeAlD
Desogestrel—SHBG—testis—ovarian cancer	0.00105	0.0112	CbGeAlD
Desogestrel—ESR1—gonad—ovarian cancer	0.00102	0.011	CbGeAlD
Desogestrel—ESR1—uterus—ovarian cancer	0.00102	0.0109	CbGeAlD
Desogestrel—Neoplasm—Topotecan—ovarian cancer	0.000976	0.018	CcSEcCtD
Desogestrel—Neoplasm—Melphalan—ovarian cancer	0.000955	0.0177	CcSEcCtD
Desogestrel—PGR—testis—ovarian cancer	0.000942	0.0101	CbGeAlD
Desogestrel—ESR1—female reproductive system—ovarian cancer	0.000913	0.00982	CbGeAlD
Desogestrel—ESR1—female gonad—ovarian cancer	0.000831	0.00893	CbGeAlD
Desogestrel—ESR1—vagina—ovarian cancer	0.000826	0.00888	CbGeAlD
Desogestrel—Erythema nodosum—Epirubicin—ovarian cancer	0.000821	0.0152	CcSEcCtD
Desogestrel—Vomiting—Altretamine—ovarian cancer	0.000774	0.0143	CcSEcCtD
Desogestrel—Erythema nodosum—Doxorubicin—ovarian cancer	0.00076	0.014	CcSEcCtD
Desogestrel—ESR1—testis—ovarian cancer	0.000737	0.00792	CbGeAlD
Desogestrel—Norelgestromin—PGR—ovarian cancer	0.000727	0.105	CrCbGaD
Desogestrel—Allylestrenol—PGR—ovarian cancer	0.000727	0.105	CrCbGaD
Desogestrel—Nausea—Altretamine—ovarian cancer	0.000723	0.0134	CcSEcCtD
Desogestrel—Breast pain—Paclitaxel—ovarian cancer	0.000712	0.0132	CcSEcCtD
Desogestrel—PGR—lymph node—ovarian cancer	0.000683	0.00734	CbGeAlD
Desogestrel—Norgestimate—PGR—ovarian cancer	0.000655	0.0948	CrCbGaD
Desogestrel—Weight increased—Topotecan—ovarian cancer	0.000616	0.0114	CcSEcCtD
Desogestrel—Quinestrol—ESR1—ovarian cancer	0.00059	0.0854	CrCbGaD
Desogestrel—Fluid retention—Paclitaxel—ovarian cancer	0.00059	0.0109	CcSEcCtD
Desogestrel—Vaginal discharge—Epirubicin—ovarian cancer	0.000584	0.0108	CcSEcCtD
Desogestrel—Erythema multiforme—Chlorambucil—ovarian cancer	0.000576	0.0106	CcSEcCtD
Desogestrel—Etonogestrel—PGR—ovarian cancer	0.000567	0.082	CrCbGaD
Desogestrel—Neoplasm—Paclitaxel—ovarian cancer	0.000561	0.0104	CcSEcCtD
Desogestrel—Vaginal discharge—Doxorubicin—ovarian cancer	0.00054	0.00998	CcSEcCtD
Desogestrel—Alopecia—Chlorambucil—ovarian cancer	0.000538	0.00994	CcSEcCtD
Desogestrel—ESR1—lymph node—ovarian cancer	0.000534	0.00574	CbGeAlD
Desogestrel—Weight decreased—Vinorelbine—ovarian cancer	0.000524	0.00969	CcSEcCtD
Desogestrel—Fluid retention—Docetaxel—ovarian cancer	0.0005	0.00924	CcSEcCtD
Desogestrel—Immune system disorder—Topotecan—ovarian cancer	0.00049	0.00905	CcSEcCtD
Desogestrel—Immune system disorder—Melphalan—ovarian cancer	0.000479	0.00886	CcSEcCtD
Desogestrel—Alopecia—Topotecan—ovarian cancer	0.000479	0.00885	CcSEcCtD
Desogestrel—Neoplasm—Docetaxel—ovarian cancer	0.000476	0.0088	CcSEcCtD
Desogestrel—Malnutrition—Topotecan—ovarian cancer	0.000472	0.00872	CcSEcCtD
Desogestrel—Alopecia—Melphalan—ovarian cancer	0.000469	0.00867	CcSEcCtD
Desogestrel—Allylestrenol—ESR1—ovarian cancer	0.000459	0.0664	CrCbGaD
Desogestrel—Mestranol—ESR1—ovarian cancer	0.000447	0.0647	CrCbGaD
Desogestrel—Mood swings—Paclitaxel—ovarian cancer	0.000427	0.00789	CcSEcCtD
Desogestrel—Immune system disorder—Vinorelbine—ovarian cancer	0.000419	0.00774	CcSEcCtD
Desogestrel—Norgestimate—ESR1—ovarian cancer	0.000413	0.0598	CrCbGaD
Desogestrel—Alopecia—Vinorelbine—ovarian cancer	0.00041	0.00757	CcSEcCtD
Desogestrel—Breast disorder—Paclitaxel—ovarian cancer	0.000407	0.00753	CcSEcCtD
Desogestrel—Breast pain—Epirubicin—ovarian cancer	0.000407	0.00752	CcSEcCtD
Desogestrel—Malnutrition—Vinorelbine—ovarian cancer	0.000404	0.00746	CcSEcCtD
Desogestrel—Levonorgestrel—PGR—ovarian cancer	0.000401	0.058	CrCbGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000399	0.00737	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000391	0.00722	CcSEcCtD
Desogestrel—Nervous system disorder—Topotecan—ovarian cancer	0.000378	0.00698	CcSEcCtD
Desogestrel—Breast pain—Doxorubicin—ovarian cancer	0.000377	0.00696	CcSEcCtD
Desogestrel—Migraine—Docetaxel—ovarian cancer	0.000376	0.00695	CcSEcCtD
Desogestrel—Skin disorder—Topotecan—ovarian cancer	0.000374	0.00691	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000373	0.0069	CcSEcCtD
Desogestrel—Skin disorder—Melphalan—ovarian cancer	0.000366	0.00677	CcSEcCtD
Desogestrel—Danazol—PGR—ovarian cancer	0.000365	0.0528	CrCbGaD
Desogestrel—Etonogestrel—ESR1—ovarian cancer	0.000358	0.0518	CrCbGaD
Desogestrel—Weight increased—Paclitaxel—ovarian cancer	0.000355	0.00655	CcSEcCtD
Desogestrel—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000354	0.00654	CcSEcCtD
Desogestrel—Weight decreased—Paclitaxel—ovarian cancer	0.000352	0.00652	CcSEcCtD
Desogestrel—Hypertension—Vinorelbine—ovarian cancer	0.000348	0.00644	CcSEcCtD
Desogestrel—Breast disorder—Docetaxel—ovarian cancer	0.000345	0.00638	CcSEcCtD
Desogestrel—Urticaria—Chlorambucil—ovarian cancer	0.000344	0.00635	CcSEcCtD
Desogestrel—Abdominal pain—Chlorambucil—ovarian cancer	0.000342	0.00632	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000341	0.00631	CcSEcCtD
Desogestrel—Fluid retention—Epirubicin—ovarian cancer	0.000337	0.00623	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000332	0.00614	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000326	0.00602	CcSEcCtD
Desogestrel—Norethindrone—PGR—ovarian cancer	0.000325	0.047	CrCbGaD
Desogestrel—Nervous system disorder—Vinorelbine—ovarian cancer	0.000323	0.00597	CcSEcCtD
Desogestrel—Neoplasm—Epirubicin—ovarian cancer	0.000321	0.00593	CcSEcCtD
Desogestrel—Skin disorder—Vinorelbine—ovarian cancer	0.00032	0.00591	CcSEcCtD
Desogestrel—Hypersensitivity—Chlorambucil—ovarian cancer	0.000319	0.00589	CcSEcCtD
Desogestrel—Gastrointestinal pain—Topotecan—ovarian cancer	0.000315	0.00582	CcSEcCtD
Desogestrel—Fluid retention—Doxorubicin—ovarian cancer	0.000312	0.00576	CcSEcCtD
Desogestrel—Urticaria—Topotecan—ovarian cancer	0.000306	0.00565	CcSEcCtD
Desogestrel—Abdominal pain—Topotecan—ovarian cancer	0.000304	0.00563	CcSEcCtD
Desogestrel—Weight increased—Docetaxel—ovarian cancer	0.000301	0.00556	CcSEcCtD
Desogestrel—Urticaria—Melphalan—ovarian cancer	0.0003	0.00554	CcSEcCtD
Desogestrel—Weight decreased—Docetaxel—ovarian cancer	0.000299	0.00552	CcSEcCtD
Desogestrel—Neoplasm—Doxorubicin—ovarian cancer	0.000297	0.00549	CcSEcCtD
Desogestrel—Diarrhoea—Chlorambucil—ovarian cancer	0.000296	0.00547	CcSEcCtD
Desogestrel—Erythema multiforme—Paclitaxel—ovarian cancer	0.000295	0.00545	CcSEcCtD
Desogestrel—Eye disorder—Paclitaxel—ovarian cancer	0.000291	0.00539	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000284	0.00526	CcSEcCtD
Desogestrel—Hypersensitivity—Topotecan—ovarian cancer	0.000284	0.00524	CcSEcCtD
Desogestrel—Immune system disorder—Paclitaxel—ovarian cancer	0.000282	0.00521	CcSEcCtD
Desogestrel—Hypersensitivity—Melphalan—ovarian cancer	0.000278	0.00513	CcSEcCtD
Desogestrel—Alopecia—Paclitaxel—ovarian cancer	0.000276	0.00509	CcSEcCtD
Desogestrel—Vomiting—Chlorambucil—ovarian cancer	0.000275	0.00508	CcSEcCtD
Desogestrel—Mental disorder—Paclitaxel—ovarian cancer	0.000273	0.00505	CcSEcCtD
Desogestrel—Malnutrition—Paclitaxel—ovarian cancer	0.000271	0.00502	CcSEcCtD
Desogestrel—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000269	0.00498	CcSEcCtD
Desogestrel—Diarrhoea—Topotecan—ovarian cancer	0.000263	0.00487	CcSEcCtD
Desogestrel—Urticaria—Vinorelbine—ovarian cancer	0.000262	0.00484	CcSEcCtD
Desogestrel—Abdominal pain—Vinorelbine—ovarian cancer	0.00026	0.00481	CcSEcCtD
Desogestrel—Diarrhoea—Melphalan—ovarian cancer	0.000258	0.00477	CcSEcCtD
Desogestrel—Nausea—Chlorambucil—ovarian cancer	0.000257	0.00475	CcSEcCtD
Desogestrel—Affect lability—Epirubicin—ovarian cancer	0.000254	0.00469	CcSEcCtD
Desogestrel—Migraine—Epirubicin—ovarian cancer	0.000254	0.00469	CcSEcCtD
Desogestrel—Levonorgestrel—ESR1—ovarian cancer	0.000253	0.0366	CrCbGaD
Desogestrel—Erythema multiforme—Docetaxel—ovarian cancer	0.00025	0.00462	CcSEcCtD
Desogestrel—Eye disorder—Docetaxel—ovarian cancer	0.000247	0.00457	CcSEcCtD
Desogestrel—Vomiting—Topotecan—ovarian cancer	0.000245	0.00453	CcSEcCtD
Desogestrel—Mood swings—Epirubicin—ovarian cancer	0.000244	0.00451	CcSEcCtD
Desogestrel—Rash—Topotecan—ovarian cancer	0.000243	0.00449	CcSEcCtD
Desogestrel—Hypersensitivity—Vinorelbine—ovarian cancer	0.000243	0.00449	CcSEcCtD
Desogestrel—Dermatitis—Topotecan—ovarian cancer	0.000243	0.00448	CcSEcCtD
Desogestrel—Headache—Topotecan—ovarian cancer	0.000241	0.00446	CcSEcCtD
Desogestrel—Vomiting—Melphalan—ovarian cancer	0.00024	0.00443	CcSEcCtD
Desogestrel—Immune system disorder—Docetaxel—ovarian cancer	0.000239	0.00441	CcSEcCtD
Desogestrel—Rash—Melphalan—ovarian cancer	0.000238	0.00439	CcSEcCtD
Desogestrel—Dermatitis—Melphalan—ovarian cancer	0.000238	0.00439	CcSEcCtD
Desogestrel—Affect lability—Doxorubicin—ovarian cancer	0.000235	0.00434	CcSEcCtD
Desogestrel—Migraine—Doxorubicin—ovarian cancer	0.000235	0.00434	CcSEcCtD
Desogestrel—Hypertension—Paclitaxel—ovarian cancer	0.000234	0.00433	CcSEcCtD
Desogestrel—Alopecia—Docetaxel—ovarian cancer	0.000234	0.00432	CcSEcCtD
Desogestrel—Breast disorder—Epirubicin—ovarian cancer	0.000233	0.0043	CcSEcCtD
Desogestrel—Mental disorder—Docetaxel—ovarian cancer	0.000232	0.00428	CcSEcCtD
Desogestrel—Danazol—ESR1—ovarian cancer	0.000231	0.0334	CrCbGaD
Desogestrel—Malnutrition—Docetaxel—ovarian cancer	0.00023	0.00425	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00023	0.00424	CcSEcCtD
Desogestrel—Nausea—Topotecan—ovarian cancer	0.000229	0.00423	CcSEcCtD
Desogestrel—Mood swings—Doxorubicin—ovarian cancer	0.000226	0.00418	CcSEcCtD
Desogestrel—Diarrhoea—Vinorelbine—ovarian cancer	0.000225	0.00417	CcSEcCtD
Desogestrel—Nausea—Melphalan—ovarian cancer	0.000224	0.00414	CcSEcCtD
Desogestrel—Nervous system disorder—Paclitaxel—ovarian cancer	0.000217	0.00402	CcSEcCtD
Desogestrel—Breast disorder—Doxorubicin—ovarian cancer	0.000215	0.00398	CcSEcCtD
Desogestrel—Skin disorder—Paclitaxel—ovarian cancer	0.000215	0.00398	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR1—ovarian cancer	0.000213	0.0309	CrCbGaD
Desogestrel—Vomiting—Vinorelbine—ovarian cancer	0.000209	0.00387	CcSEcCtD
Desogestrel—Rash—Vinorelbine—ovarian cancer	0.000208	0.00384	CcSEcCtD
Desogestrel—Dermatitis—Vinorelbine—ovarian cancer	0.000207	0.00384	CcSEcCtD
Desogestrel—Headache—Vinorelbine—ovarian cancer	0.000206	0.00381	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—EREG—ovarian cancer	0.000206	0.00346	CbGpPWpGaD
Desogestrel—ESR1—LKB1 signaling events—MTOR—ovarian cancer	0.000205	0.00344	CbGpPWpGaD
Desogestrel—Weight increased—Epirubicin—ovarian cancer	0.000203	0.00375	CcSEcCtD
Desogestrel—Weight decreased—Epirubicin—ovarian cancer	0.000202	0.00372	CcSEcCtD
Desogestrel—Hypertension—Docetaxel—ovarian cancer	0.000199	0.00367	CcSEcCtD
Desogestrel—Nausea—Vinorelbine—ovarian cancer	0.000196	0.00362	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000195	0.0036	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—PGR—ovarian cancer	0.000193	0.00324	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000191	0.00354	CcSEcCtD
Desogestrel—ESR1—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000189	0.00317	CbGpPWpGaD
Desogestrel—Weight increased—Doxorubicin—ovarian cancer	0.000188	0.00347	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—CCND1—ovarian cancer	0.000187	0.00314	CbGpPWpGaD
Desogestrel—Weight decreased—Doxorubicin—ovarian cancer	0.000186	0.00345	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—ovarian cancer	0.000185	0.00311	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—WDR77—ovarian cancer	0.000185	0.0031	CbGpPWpGaD
Desogestrel—Nervous system disorder—Docetaxel—ovarian cancer	0.000184	0.0034	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—MMP2—ovarian cancer	0.000184	0.00309	CbGpPWpGaD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—ovarian cancer	0.000183	0.00306	CbGpPWpGaD
Desogestrel—Skin disorder—Docetaxel—ovarian cancer	0.000182	0.00337	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000182	0.00306	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000181	0.00304	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000181	0.00335	CcSEcCtD
Desogestrel—Urticaria—Paclitaxel—ovarian cancer	0.000176	0.00325	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—ESR1—ovarian cancer	0.000176	0.00295	CbGpPWpGaD
Desogestrel—Abdominal pain—Paclitaxel—ovarian cancer	0.000175	0.00324	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—IL6ST—ovarian cancer	0.000173	0.0029	CbGpPWpGaD
Desogestrel—Erythema multiforme—Epirubicin—ovarian cancer	0.000169	0.00312	CcSEcCtD
Desogestrel—ESR1—Estrogen signaling pathway—AKT1—ovarian cancer	0.000168	0.00283	CbGpPWpGaD
Desogestrel—Eye disorder—Epirubicin—ovarian cancer	0.000167	0.00308	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000166	0.00278	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—NRAS—ovarian cancer	0.000164	0.00275	CbGpPWpGaD
Desogestrel—Hypersensitivity—Paclitaxel—ovarian cancer	0.000163	0.00302	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000162	0.003	CcSEcCtD
Desogestrel—Immune system disorder—Epirubicin—ovarian cancer	0.000161	0.00298	CcSEcCtD
Desogestrel—ESR1—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00016	0.00269	CbGpPWpGaD
Desogestrel—Alopecia—Epirubicin—ovarian cancer	0.000158	0.00291	CcSEcCtD
Desogestrel—Mental disorder—Epirubicin—ovarian cancer	0.000156	0.00289	CcSEcCtD
Desogestrel—Erythema multiforme—Doxorubicin—ovarian cancer	0.000156	0.00288	CcSEcCtD
Desogestrel—PGR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000156	0.00261	CbGpPWpGaD
Desogestrel—Malnutrition—Epirubicin—ovarian cancer	0.000155	0.00287	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000155	0.0026	CbGpPWpGaD
Desogestrel—Eye disorder—Doxorubicin—ovarian cancer	0.000154	0.00285	CcSEcCtD
Desogestrel—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000154	0.00284	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—CXCL8—ovarian cancer	0.000153	0.00257	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000152	0.00254	CbGpPWpGaD
Desogestrel—Diarrhoea—Paclitaxel—ovarian cancer	0.000152	0.0028	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.00015	0.00252	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—MYC—ovarian cancer	0.00015	0.00252	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.00015	0.00251	CbGpPWpGaD
Desogestrel—Immune system disorder—Doxorubicin—ovarian cancer	0.000149	0.00275	CcSEcCtD
Desogestrel—Abdominal pain—Docetaxel—ovarian cancer	0.000148	0.00274	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—MYC—ovarian cancer	0.000147	0.00247	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—PIK3CD—ovarian cancer	0.000146	0.00245	CbGpPWpGaD
Desogestrel—Alopecia—Doxorubicin—ovarian cancer	0.000146	0.00269	CcSEcCtD
Desogestrel—PGR—Gene Expression—TTF1—ovarian cancer	0.000145	0.00243	CbGpPWpGaD
Desogestrel—Mental disorder—Doxorubicin—ovarian cancer	0.000145	0.00267	CcSEcCtD
Desogestrel—Malnutrition—Doxorubicin—ovarian cancer	0.000144	0.00265	CcSEcCtD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—ovarian cancer	0.000143	0.00239	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—CCND1—ovarian cancer	0.000143	0.00239	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—MTOR—ovarian cancer	0.000142	0.00238	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—ovarian cancer	0.000141	0.00237	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HSD17B6—ovarian cancer	0.000141	0.00237	CbGpPWpGaD
Desogestrel—Vomiting—Paclitaxel—ovarian cancer	0.000141	0.0026	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.00014	0.00235	CbGpPWpGaD
Desogestrel—Rash—Paclitaxel—ovarian cancer	0.00014	0.00258	CcSEcCtD
Desogestrel—Dermatitis—Paclitaxel—ovarian cancer	0.00014	0.00258	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.00014	0.00234	CbGpPWpGaD
Desogestrel—Headache—Paclitaxel—ovarian cancer	0.000139	0.00257	CcSEcCtD
Desogestrel—Hypersensitivity—Docetaxel—ovarian cancer	0.000138	0.00256	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000137	0.0023	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000137	0.00229	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000136	0.00229	CbGpPWpGaD
Desogestrel—Hypertension—Epirubicin—ovarian cancer	0.000134	0.00248	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—ovarian cancer	0.000134	0.00224	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.000133	0.00224	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—CDKN1B—ovarian cancer	0.000133	0.00224	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—ERBB2—ovarian cancer	0.000133	0.00223	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—NR5A1—ovarian cancer	0.000132	0.00221	CbGpPWpGaD
Desogestrel—Nausea—Paclitaxel—ovarian cancer	0.000132	0.00243	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—MTOR—ovarian cancer	0.000131	0.0022	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000131	0.00243	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—IL2—ovarian cancer	0.000131	0.00219	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.00013	0.00219	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—ovarian cancer	0.00013	0.00218	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—ERBB2—ovarian cancer	0.000129	0.00216	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000129	0.00216	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000129	0.00216	CbGpPWpGaD
Desogestrel—Diarrhoea—Docetaxel—ovarian cancer	0.000128	0.00238	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—IL2—ovarian cancer	0.000128	0.00214	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—PIK3CB—ovarian cancer	0.000127	0.00213	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—MTOR—ovarian cancer	0.000127	0.00213	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—CCND1—ovarian cancer	0.000127	0.00213	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000127	0.00212	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CCND1—ovarian cancer	0.000124	0.00209	CbGpPWpGaD
Desogestrel—Nervous system disorder—Epirubicin—ovarian cancer	0.000124	0.0023	CcSEcCtD
Desogestrel—Hypertension—Doxorubicin—ovarian cancer	0.000124	0.00229	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000123	0.00206	CbGpPWpGaD
Desogestrel—Skin disorder—Epirubicin—ovarian cancer	0.000123	0.00227	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000121	0.00224	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—TP53—ovarian cancer	0.000121	0.00203	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MMP9—ovarian cancer	0.000121	0.00202	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ovarian cancer	0.00012	0.00202	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—DLC1—ovarian cancer	0.00012	0.00201	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—PTEN—ovarian cancer	0.00012	0.00201	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—CDKN1B—ovarian cancer	0.000119	0.002	CbGpPWpGaD
Desogestrel—Vomiting—Docetaxel—ovarian cancer	0.000119	0.00221	CcSEcCtD
Desogestrel—Rash—Docetaxel—ovarian cancer	0.000118	0.00219	CcSEcCtD
Desogestrel—Dermatitis—Docetaxel—ovarian cancer	0.000118	0.00219	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—CCND1—ovarian cancer	0.000118	0.00197	CbGpPWpGaD
Desogestrel—Headache—Docetaxel—ovarian cancer	0.000118	0.00217	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—MAPK3—ovarian cancer	0.000118	0.00197	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000116	0.00195	CbGpPWpGaD
Desogestrel—Nervous system disorder—Doxorubicin—ovarian cancer	0.000115	0.00212	CcSEcCtD
Desogestrel—Skin disorder—Doxorubicin—ovarian cancer	0.000114	0.0021	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000113	0.00189	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000113	0.00189	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—MAPK1—ovarian cancer	0.000112	0.00188	CbGpPWpGaD
Desogestrel—Nausea—Docetaxel—ovarian cancer	0.000112	0.00206	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000111	0.00186	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—PTEN—ovarian cancer	0.00011	0.00184	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.00011	0.00184	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000109	0.00202	CcSEcCtD
Desogestrel—ESR1—Gene Expression—WDR77—ovarian cancer	0.000108	0.00182	CbGpPWpGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ovarian cancer	0.000107	0.0018	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ovarian cancer	0.000106	0.00178	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—MAPK3—ovarian cancer	0.000105	0.00176	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000104	0.00191	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—MYC—ovarian cancer	0.000102	0.00171	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—STAT3—ovarian cancer	0.000102	0.0017	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IL6ST—ovarian cancer	0.000101	0.0017	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000101	0.00187	CcSEcCtD
Desogestrel—Urticaria—Epirubicin—ovarian cancer	0.000101	0.00186	CcSEcCtD
Desogestrel—Abdominal pain—Epirubicin—ovarian cancer	0.0001	0.00185	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—MAPK1—ovarian cancer	9.98e-05	0.00167	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—EGFR—ovarian cancer	9.98e-05	0.00167	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MYC—ovarian cancer	9.97e-05	0.00167	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—NRAS—ovarian cancer	9.81e-05	0.00165	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—BCL9—ovarian cancer	9.79e-05	0.00164	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—MAPK3—ovarian cancer	9.7e-05	0.00163	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.58e-05	0.00177	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—MAPK3—ovarian cancer	9.4e-05	0.00158	CbGpPWpGaD
Desogestrel—Hypersensitivity—Epirubicin—ovarian cancer	9.33e-05	0.00173	CcSEcCtD
Desogestrel—Urticaria—Doxorubicin—ovarian cancer	9.31e-05	0.00172	CcSEcCtD
Desogestrel—Abdominal pain—Doxorubicin—ovarian cancer	9.26e-05	0.00171	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—MAPK1—ovarian cancer	9.23e-05	0.00155	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—YAP1—ovarian cancer	9.15e-05	0.00153	CbGpPWpGaD
Desogestrel—Ethinyl Estradiol—ABCB1—ovarian cancer	9.06e-05	0.0131	CrCbGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	9.02e-05	0.00151	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—MAPK1—ovarian cancer	8.94e-05	0.0015	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—EGFR—ovarian cancer	8.94e-05	0.0015	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	8.87e-05	0.00149	CbGpPWpGaD
Desogestrel—Norethindrone—ABCB1—ovarian cancer	8.71e-05	0.0126	CrCbGaD
Desogestrel—Diarrhoea—Epirubicin—ovarian cancer	8.67e-05	0.0016	CcSEcCtD
Desogestrel—Hypersensitivity—Doxorubicin—ovarian cancer	8.63e-05	0.0016	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—IL6—ovarian cancer	8.6e-05	0.00144	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PIK3CD—ovarian cancer	8.57e-05	0.00144	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—TTF1—ovarian cancer	8.51e-05	0.00143	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—KRAS—ovarian cancer	8.44e-05	0.00142	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HSD17B6—ovarian cancer	8.29e-05	0.00139	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—TP53—ovarian cancer	8.19e-05	0.00137	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	8.12e-05	0.00136	CbGpPWpGaD
Desogestrel—Vomiting—Epirubicin—ovarian cancer	8.05e-05	0.00149	CcSEcCtD
Desogestrel—Diarrhoea—Doxorubicin—ovarian cancer	8.02e-05	0.00148	CcSEcCtD
Desogestrel—ESR1—Generic Transcription Pathway—PGR—ovarian cancer	7.99e-05	0.00134	CbGpPWpGaD
Desogestrel—Rash—Epirubicin—ovarian cancer	7.99e-05	0.00148	CcSEcCtD
Desogestrel—Dermatitis—Epirubicin—ovarian cancer	7.98e-05	0.00147	CcSEcCtD
Desogestrel—Headache—Epirubicin—ovarian cancer	7.94e-05	0.00147	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—PIK3CA—ovarian cancer	7.76e-05	0.0013	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—DOK1—ovarian cancer	7.74e-05	0.0013	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NR5A1—ovarian cancer	7.73e-05	0.0013	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—ERBB2—ovarian cancer	7.57e-05	0.00127	CbGpPWpGaD
Desogestrel—Nausea—Epirubicin—ovarian cancer	7.52e-05	0.00139	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	7.51e-05	0.00126	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—YAP1—ovarian cancer	7.51e-05	0.00126	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—IL6—ovarian cancer	7.5e-05	0.00126	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—MTOR—ovarian cancer	7.47e-05	0.00125	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PIK3CB—ovarian cancer	7.47e-05	0.00125	CbGpPWpGaD
Desogestrel—Vomiting—Doxorubicin—ovarian cancer	7.45e-05	0.00138	CcSEcCtD
Desogestrel—ESR1—Generic Transcription Pathway—PARP1—ovarian cancer	7.43e-05	0.00125	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—HRAS—ovarian cancer	7.41e-05	0.00124	CbGpPWpGaD
Desogestrel—Rash—Doxorubicin—ovarian cancer	7.39e-05	0.00137	CcSEcCtD
Desogestrel—Dermatitis—Doxorubicin—ovarian cancer	7.38e-05	0.00136	CcSEcCtD
Desogestrel—Headache—Doxorubicin—ovarian cancer	7.34e-05	0.00136	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—PPP1CC—ovarian cancer	7.28e-05	0.00122	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ESR1—ovarian cancer	7.27e-05	0.00122	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—HRAS—ovarian cancer	7.18e-05	0.0012	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—AKT1—ovarian cancer	7.08e-05	0.00119	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—DLC1—ovarian cancer	7.05e-05	0.00118	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—CDKN1B—ovarian cancer	7.01e-05	0.00118	CbGpPWpGaD
Desogestrel—Nausea—Doxorubicin—ovarian cancer	6.96e-05	0.00129	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	6.91e-05	0.00116	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—IL6—ovarian cancer	6.87e-05	0.00115	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	6.72e-05	0.00113	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	6.66e-05	0.00112	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—AKT1—ovarian cancer	6.54e-05	0.0011	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	6.49e-05	0.00109	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PTEN—ovarian cancer	6.45e-05	0.00108	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—AKT1—ovarian cancer	6.34e-05	0.00106	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	6.3e-05	0.00106	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	6.15e-05	0.00103	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—PARP1—ovarian cancer	6.09e-05	0.00102	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	5.86e-05	0.000983	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	5.84e-05	0.000979	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—NRAS—ovarian cancer	5.76e-05	0.000966	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BCL9—ovarian cancer	5.75e-05	0.000964	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	5.72e-05	0.00096	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	5.57e-05	0.000934	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	5.52e-05	0.000925	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HDAC6—ovarian cancer	5.51e-05	0.000925	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—MAPK3—ovarian cancer	5.51e-05	0.000925	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	5.39e-05	0.000904	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	5.38e-05	0.000902	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	5.27e-05	0.000885	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	5.27e-05	0.000884	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	5.25e-05	0.00088	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	5.25e-05	0.00088	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	4.98e-05	0.000835	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	4.96e-05	0.000831	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—PPP2R1A—ovarian cancer	4.94e-05	0.000829	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—YAP1—ovarian cancer	4.88e-05	0.000819	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	4.86e-05	0.000814	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—XIAP—ovarian cancer	4.78e-05	0.000802	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SMARCA4—ovarian cancer	4.66e-05	0.000781	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	4.59e-05	0.00077	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	4.55e-05	0.000764	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EREG—ovarian cancer	4.55e-05	0.000763	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—DOK1—ovarian cancer	4.54e-05	0.000762	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	4.47e-05	0.000749	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	4.43e-05	0.000743	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—YAP1—ovarian cancer	4.41e-05	0.000739	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.37e-05	0.000733	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.37e-05	0.000733	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	4.27e-05	0.000716	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	4.21e-05	0.000706	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.13e-05	0.000692	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—IL6—ovarian cancer	4.03e-05	0.000676	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PARP1—ovarian cancer	3.96e-05	0.000664	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PGR—ovarian cancer	3.85e-05	0.000645	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.79e-05	0.000636	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—MYC—ovarian cancer	3.78e-05	0.000634	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	3.74e-05	0.000627	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	3.72e-05	0.000624	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.67e-05	0.000615	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PARP1—ovarian cancer	3.58e-05	0.0006	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR1—ovarian cancer	3.5e-05	0.000587	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HDAC6—ovarian cancer	3.24e-05	0.000543	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PPP2R1A—ovarian cancer	3.21e-05	0.000539	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.1e-05	0.00052	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PPP2R1A—ovarian cancer	2.9e-05	0.000487	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—YAP1—ovarian cancer	2.86e-05	0.00048	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—XIAP—ovarian cancer	2.81e-05	0.000471	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	2.73e-05	0.000459	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EREG—ovarian cancer	2.67e-05	0.000448	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TERT—ovarian cancer	2.55e-05	0.000428	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PGR—ovarian cancer	2.5e-05	0.000419	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CAV1—ovarian cancer	2.36e-05	0.000396	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PARP1—ovarian cancer	2.33e-05	0.00039	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ESR1—ovarian cancer	2.28e-05	0.000382	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL6ST—ovarian cancer	2.24e-05	0.000375	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	2.22e-05	0.000372	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CG—ovarian cancer	2.15e-05	0.000361	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—APC—ovarian cancer	2.15e-05	0.000361	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CD—ovarian cancer	1.89e-05	0.000317	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	1.89e-05	0.000316	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MAPK3—ovarian cancer	1.87e-05	0.000314	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MYC—ovarian cancer	1.82e-05	0.000305	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB2—ovarian cancer	1.67e-05	0.00028	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CB—ovarian cancer	1.65e-05	0.000276	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MTOR—ovarian cancer	1.65e-05	0.000276	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCL8—ovarian cancer	1.58e-05	0.000266	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1B—ovarian cancer	1.55e-05	0.000259	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CASP3—ovarian cancer	1.52e-05	0.000254	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL2—ovarian cancer	1.51e-05	0.000254	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TERT—ovarian cancer	1.5e-05	0.000251	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CCND1—ovarian cancer	1.48e-05	0.000247	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CTNNB1—ovarian cancer	1.46e-05	0.000245	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MMP9—ovarian cancer	1.43e-05	0.00024	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTEN—ovarian cancer	1.42e-05	0.000239	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CAV1—ovarian cancer	1.39e-05	0.000232	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL6ST—ovarian cancer	1.31e-05	0.00022	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—VEGFA—ovarian cancer	1.29e-05	0.000216	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—STAT3—ovarian cancer	1.27e-05	0.000214	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NRAS—ovarian cancer	1.27e-05	0.000213	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	1.26e-05	0.000212	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—APC—ovarian cancer	1.26e-05	0.000212	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—AKT1—ovarian cancer	1.26e-05	0.000212	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAPK3—ovarian cancer	1.22e-05	0.000204	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MYC—ovarian cancer	1.18e-05	0.000199	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MAPK1—ovarian cancer	1.16e-05	0.000194	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGFR—ovarian cancer	1.16e-05	0.000194	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	1.11e-05	0.000186	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MAPK3—ovarian cancer	1.1e-05	0.000184	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KRAS—ovarian cancer	1.09e-05	0.000183	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MYC—ovarian cancer	1.07e-05	0.000179	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PIK3CA—ovarian cancer	1e-05	0.000169	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB2—ovarian cancer	9.8e-06	0.000164	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—ovarian cancer	9.72e-06	0.000163	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	9.67e-06	0.000162	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MTOR—ovarian cancer	9.67e-06	0.000162	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL8—ovarian cancer	9.3e-06	0.000156	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HRAS—ovarian cancer	9.3e-06	0.000156	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	9.08e-06	0.000152	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CASP3—ovarian cancer	8.9e-06	0.000149	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL6—ovarian cancer	8.9e-06	0.000149	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL2—ovarian cancer	8.88e-06	0.000149	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCND1—ovarian cancer	8.66e-06	0.000145	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	8.58e-06	0.000144	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MMP9—ovarian cancer	8.41e-06	0.000141	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTEN—ovarian cancer	8.36e-06	0.00014	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—AKT1—ovarian cancer	8.21e-06	0.000138	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VEGFA—ovarian cancer	7.55e-06	0.000127	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—STAT3—ovarian cancer	7.48e-06	0.000125	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NRAS—ovarian cancer	7.46e-06	0.000125	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—AKT1—ovarian cancer	7.41e-06	0.000124	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAPK3—ovarian cancer	7.14e-06	0.00012	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MYC—ovarian cancer	6.95e-06	0.000117	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MAPK1—ovarian cancer	6.8e-06	0.000114	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGFR—ovarian cancer	6.79e-06	0.000114	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KRAS—ovarian cancer	6.42e-06	0.000108	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	5.9e-06	9.89e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—ovarian cancer	5.71e-06	9.57e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HRAS—ovarian cancer	5.46e-06	9.15e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL6—ovarian cancer	5.22e-06	8.76e-05	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—AKT1—ovarian cancer	4.82e-06	8.08e-05	CbGpPWpGaD
